Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP618065.RA_9z1RdLilSm6cwXr5cjt-2XM9urr3A48je5hxahvPxI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP618065.RA_9z1RdLilSm6cwXr5cjt-2XM9urr3A48je5hxahvPxI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP618065.RA_9z1RdLilSm6cwXr5cjt-2XM9urr3A48je5hxahvPxI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP618065.RA_9z1RdLilSm6cwXr5cjt-2XM9urr3A48je5hxahvPxI130_provenance.
- NP618065.RA_9z1RdLilSm6cwXr5cjt-2XM9urr3A48je5hxahvPxI130_assertion description "[Because HDAC inhibition disrupts the chaperon function of heat shock protein (HSP) 90, we hypothesized that the combination of 17-allylamino-17-demethoxygeldanamycin (17-AAG), an inhibitor of HSP90, and the HIV protease inhibitor ritonavir would also act against renal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618065.RA_9z1RdLilSm6cwXr5cjt-2XM9urr3A48je5hxahvPxI130_provenance.
- NP618065.RA_9z1RdLilSm6cwXr5cjt-2XM9urr3A48je5hxahvPxI130_assertion evidence source_evidence_literature NP618065.RA_9z1RdLilSm6cwXr5cjt-2XM9urr3A48je5hxahvPxI130_provenance.
- NP618065.RA_9z1RdLilSm6cwXr5cjt-2XM9urr3A48je5hxahvPxI130_assertion SIO_000772 22470109 NP618065.RA_9z1RdLilSm6cwXr5cjt-2XM9urr3A48je5hxahvPxI130_provenance.
- NP618065.RA_9z1RdLilSm6cwXr5cjt-2XM9urr3A48je5hxahvPxI130_assertion wasDerivedFrom befree-20140225 NP618065.RA_9z1RdLilSm6cwXr5cjt-2XM9urr3A48je5hxahvPxI130_provenance.
- NP618065.RA_9z1RdLilSm6cwXr5cjt-2XM9urr3A48je5hxahvPxI130_assertion wasGeneratedBy ECO_0000203 NP618065.RA_9z1RdLilSm6cwXr5cjt-2XM9urr3A48je5hxahvPxI130_provenance.
- befree-20140225 importedOn "2014-02-25" NP618065.RA_9z1RdLilSm6cwXr5cjt-2XM9urr3A48je5hxahvPxI130_provenance.